Aptiv Solutions

Reston, United States Founded: 1990 • Age: 36 yrs Acquired By Icon
Clinical trial services are provided by this research organization.

About Aptiv Solutions

Aptiv Solutions is a Healthcare company based in Reston (United States) founded in 1990, and was acquired by Icon in March 2014. It operates as a clinical trial services are provided by this research organization. Aptiv Solutions has raised $5.66 million across 2 funding rounds from investors including ICON and The Halifax Group. Aptiv Solutions has completed 1 acquisition, including Medical Device Consultants. Its focus areas include Biopharma Outsourcing, CRO, Clinical Development and Full Service. Its competitors include Emmes, Syneos Health, Veristat, ClinChoice and Medelis WCCT Global and 3 more; 3 of its 8 listed competitors have raised funding.

Company details

Aptiv Solutions is a CRO that provides adaptive trial design, simulation, and execution, early phase development consulting, preclinical development and drug development services. The company also provides regulatory compliance consulting services, which include strategy development, agency advisory, legal representation, and submission management services. It offers therapeutic services in the areas of oncology, cardiology, dermatology, respiratory, and orphan diseases. Further, the company develops AptivAdvantage, an integrated technology platform for the implementation and execution of adaptive clinical trials. The company was acquired by ICON, a global CRO in March, 2014.

Key Metrics
  • Total Equity Funding
    $5.66M (USD)

    in 2 rounds

  • Latest Funding Round
    $5.66M (USD), Private Equity Round

    Apr 2012

  • Investors
    ICON

    & 1 more

  • Investments & Acquisitions
  • Acquired by
    Icon

    (Mar 2014)

Funding Insights of Aptiv Solutions

Aptiv Solutions has successfully raised a total of $5.66M across 2 strategic funding rounds. The most recent funding activity was a Private Equity Round of $5.66 million completed in April 2012. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $5.66M
  • Total Rounds 2
  • Last Round Private Equity Round β€” $5.66M
  • Investors Count 1

All 2 funding rounds of Aptiv Solutions with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Apr 2012$5.66MPrivate Equity Round––
–
Jul 2008–Private Equity Round––
Valuation history

2 investors in total: 2 institutional.

Investors in Aptiv Solutions

Aptiv Solutions has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include ICON and The Halifax Group.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Private equity investments are directed toward companies in multiple sectors.
–thehalifaxgroup.comWashington, Dc, United States
ICON plc is engaged in clinical research and drug development services.
1990iconplc.comDublin, Ireland
Premium access

Investor details for Aptiv Solutions

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Aptiv Solutions

Aptiv Solutions has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Medical Device Consultants.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Regulatory and clinical services for medical devices are offered.
mdci.comNorth Attleborough, United States1980Aug 2011β€’β€’β€’β€’
Premium access

Complete acquisition details for Aptiv Solutions

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Aptiv Solutions

5 dated milestones of Aptiv Solutions across 24 years, from founding to its latest funding, stage changes and deals.

  1. Founded Aptiv Solutions is founded.
  2. Funding First funding round.
  3. Acquisition Acquires Medical Device Consultants.
  4. Funding Latest funding round, Private Equity Round, of $5.7M.
  5. Exit Acquired by Icon.

Competitors of Aptiv Solutions

Aptiv Solutions has 8 listed competitors in our database, 3 of them funded. They include Emmes, Syneos Health, Veristat, ClinChoice and Medelis WCCT Global, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
emmes.com1977United States–195
Outsourced contract research organization services are provided to clients.
syneoshealth.com1984Raleigh, United States–29,395
CRO clinical development services are provided by Syneos Health.
veristat.com1994Southborough, United States–7
Clinical trials and regulatory submissions are supported as a CRO.
clinchoice.com1995Fort Washington, United States$212M478
CRO focused on data management, regulatory affairs and consulting services
wcct.com1998Cypress, United States$17M229
Full-service CRO expertise in influenza and oncology research is offered.
parexel.com1983Waltham, United States––
Full-service clinical research organization services are provided globally by Parexel.
celgene.com1986Summit, United States$45M4,891
Therapies for cancer and inflammatory diseases are developed.
hvivo.com1998London, United Kingdom–133
Provider of cell based assays, field trial, and molecular services for biopharma sector
Premium access

Detailed competitors of Aptiv Solutions

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Aptiv Solutions

Websites that share an audience with Aptiv Solutions (aptivsolutions.com).

Similar websites

Websites whose visitors overlap most with Aptiv Solutions. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
quintiles.com
100%
–#377,823View details
parexel.com
96%
220.8K#203,256View details
iconplc.com
73%
476.9K#92,950View details

Top companies in Biopharma Outsourcing & Drug Delivery

10 companies that operate in the same segment as Aptiv Solutions (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Developer of integrated contract research development and manufacturing services
2007Bengaluru, Karnataka, IndiaUSD 35.74 MUSD 226.38 M1,820
Drug discovery and development services are provided to biopharma sector.
1993Hamburg, Hamburg, GermanyUSD 25 MUSD 926.33 M4,830
Drug discovery and development services for small molecules are provided.
2003Beijing, ChinaUSD 320 M–476
Suite solutions are provided for payers and healthcare providers.
1998Princeton, New Jersey, United StatesUSD 220 MUSD 374.1 M4,490
Wearable insulin infusion systems are developed for diabetes patients.
2000Boston, Massachusetts, United StatesUSD 120.4 MUSD 2.71 B3,900
Developer of small-molecule drugs
1991Los Angeles, California, United StatesUSD 50 MUSD 348.97 M407
Pharmaceutical and biotechnology company
2005Hyderabad, Telangana, IndiaUSD 229.73 MUSD 726.15 M12,470
Pharmaceutical products for treating multiple diseases are provided.
1849New York, New York, United StatesUSD 8 MUSD 266.99 M1,770
Provider of laboratory tests for physicians
1969Burlington, Vermont, United States–USD 13.95 B70,000
India's leading healthcare products distribution platform
2018Mumbai, Maharashtra, IndiaUSD 59.67 MUSD 702.49 M4,260
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Aptiv Solutions

Aptiv Solutions was founded in 1990 and raised its 1st funding round 18 years after it was founded.

Aptiv Solutions is headquartered in Reston, United States. It is registered at Reston, Virginia, United States.

Aptiv Solutions is a funded company, having raised a total of $5.66M across 2 funding rounds to date.

Aptiv Solutions is a CRO that provides adaptive trial design, simulation, and execution, early phase development consulting, preclinical development and drug development services. The company also provides regulatory compliance consulting services, which include strategy development, agency advisory, legal representation, and submission management services. It offers therapeutic services in the areas of oncology, cardiology, dermatology, respiratory, and orphan diseases. Further, the company develops AptivAdvantage, an integrated technology platform for the implementation and execution of adaptive clinical trials. The company was acquired by ICON, a global CRO in March, 2014.

Aptiv Solutions's top competitors include Emmes, Syneos Health and ClinChoice.

Aptiv Solutions has made 1 acquisition, including Medical Device Consultants.

Aptiv Solutions has 2 investors. Key investors include ICON, and The Halifax Group.

Yes. Aptiv Solutions was acquired by Icon in March 2014.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available